Decisions about neoadjuvant systemic therapy for breast cancer: a survey of Australian and New Zealand specialists

被引:4
|
作者
Zdenkowski, Nicholas [1 ,2 ,3 ]
Butow, Phyllis [4 ]
Mann, Bruce [5 ]
Fewster, Sheryl [2 ]
Douglas, Charles [1 ]
Boyle, Frances M. [2 ,3 ]
机构
[1] Univ Newcastle, Sch Med & Publ Hlth, Newcastle, NSW 2300, Australia
[2] Australia & New Zealand Breast Canc Trials Grp, Newcastle, NSW, Australia
[3] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia
[4] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia
[5] Univ Melbourne, Royal Melbourne & Royal Womens Hosp, Breast Serv, Melbourne, Vic, Australia
关键词
D O I
10.1111/ans.13266
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:797 / 798
页数:2
相关论文
共 50 条
  • [21] New systemic therapy for breast cancer
    Pierre Fumoleau
    Dominique Berton-Rigaud
    Valerie Delecroix
    Franck Priou
    Stephanie Bordenave
    Breast Cancer, 1999, 6 (4) : 382 - 385
  • [22] Survey of Australian and New Zealand Oral and Maxillofacial Surgery trainees and recent specialists - education and experience
    Szuster, FSP
    Nastri, AL
    Goss, AN
    Spencer, AJ
    INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2000, 29 (04) : 305 - 308
  • [23] Controversies Concerning the Use of Neoadjuvant Systemic Therapy for Primary Breast Cancer
    Kaufmann, Manfred
    Karn, Thomas
    Ruckhaeberle, Eugen
    WORLD JOURNAL OF SURGERY, 2012, 36 (07) : 1480 - 1485
  • [24] Investigating circulating lncRNAs in breast cancer patients on neoadjuvant systemic therapy
    Krastev, Boris
    Timcheva, Constanta
    Valev, Spartak
    Zhbantov, Georgi
    Petrova, Mila
    Karanikolova, Teodora
    Gencheva, Radostina
    Ivanova, Anika
    Stoykov, Ivaylo
    Stamenov, Georgi
    CANCER RESEARCH, 2020, 80 (04)
  • [25] A survey among breast cancer specialists on the low uptake of breast cancer preventive therapy with tamoxifen or raloxifene
    De Censi, A.
    Noonan, S. F.
    Pasa, A.
    Caviglia, S.
    Bonanni, B.
    Costa, A.
    ANNALS OF ONCOLOGY, 2016, 27
  • [26] Biomarker evolution after neoadjuvant systemic therapy in breast cancer.
    Castillo, Dan Ran
    Pairawan, Seyed Saeed
    Denham, Laura
    Lum, Sharon S.
    Nagaraj, Gayathri
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [27] Neoadjuvant Systemic Therapy for Breast Cancer: Factors Influencing Surgeons' Referrals
    Mamounas, Eleftherios
    Poulos, Christine
    Goertz, Hans-Peter
    Gonzalez, Juan Marcos
    Pugh, Amy
    Antao, Vincent
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (11) : 3510 - 3517
  • [28] Neoadjuvant Systemic Therapy for Breast Cancer: Factors Influencing Surgeons’ Referrals
    Eleftherios Mamounas
    Christine Poulos
    Hans-Peter Goertz
    Juan Marcos González
    Amy Pugh
    Vincent Antao
    Annals of Surgical Oncology, 2016, 23 : 3510 - 3517
  • [29] Can we tailor neoadjuvant (primary) systemic therapy for breast cancer?
    A. Eniu
    memo - Magazine of European Medical Oncology, 2008, 1 (3) : 143 - 147
  • [30] Metaplastic Breast Cancer Has a Poor Response to Neoadjuvant Systemic Therapy
    Al-Hilli, Zahraa
    Jakub, James
    Visscher, Daniel
    Ingle, James
    Goetz, Matthew
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : 24 - 25